Cargando…
Targeting H3K27me3 loss in pediatric brain tumors - a perspective on epigenetically guided cancer therapy
Autor principal: | Goldstein, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10178451/ https://www.ncbi.nlm.nih.gov/pubmed/37171381 http://dx.doi.org/10.18632/oncotarget.28427 |
Ejemplares similares
-
Antagonistic Roles for H3K36me3 and H3K27me3 in the Cold-Induced Epigenetic Switch at Arabidopsis FLC
por: Yang, Hongchun, et al.
Publicado: (2014) -
Loss of H3K27me3 expression in canine nerve sheath tumors
por: Tekavec, Kristina, et al.
Publicado: (2022) -
Loss of HP1 causes depletion of H3K27me3 from facultative heterochromatin and gain of H3K27me2 at constitutive heterochromatin
por: Jamieson, Kirsty, et al.
Publicado: (2016) -
Epigenetic engineering shows that a human centromere resists silencing mediated by H3K27me3/K9me3
por: Martins, Nuno M. C., et al.
Publicado: (2016) -
Global analysis of H3K27me3 as an epigenetic marker in prostate cancer progression
por: Ngollo, Marjolaine, et al.
Publicado: (2017)